Projects
This section presents pharmaceutical projects that are announced from time-to-time around the world.
Piramal Pharma Invests US$90 Million to Expand Manufacturing Facilities in Kentucky and Michigan, USA
Piramal Pharma plans to invest US$90 million to expand two pharmaceutical manufacturing facilities located in Lexington, Kentucky and Riverview, Michigan, USA
Roche and Genentech Invest US$700 Million for State-of-the-Art Manufacturing Facility in North Carolina, USA
Roche and Genentech plan to invest US$700 million in the development of a cuttingedge drug manufacturing facility in Holly Springs, North Carolina, USA
LGM Pharma Invests US$6 million to Expand Drug Manufacturing Facility in USA
LGM Pharma plans to invest $6 million in expanding its manufacturing facility in Rosenberg, Texas
Delpharm Invests US$148 Million (CAD 200 Million) for State-of-the-Art Sterile Injectable Manufacturing Facility in Canada
Delpharm plans to invest US$148 million CAD 200 million to develop a stateoftheart sterile injectable manufacturing facility in Boucherville, Canada
Novartis to Invest US$23 Billion to State-of-the-Art Manufacturing and R&D Facility in USA
Novartis has announced plans to invest US$23 billion over the next five years to expand its manufacturing and RD footprint across the United States
Woodstock Sterile Solutions Invests US$8 million for State-of-the-Art Bottle Packaging Line Facility in USA
Woodstock Sterile Solutions plans to invest US$8 million to open a new stateoftheart facility in the Woodstock, Illinois
Johnson & Johnson Invests US$2 Billion in State-of-the-Art Biologics Facility in North Carolina, USA
Johnson Johnson plans to invest US$2 billion to develop a new biologics manufacturing facility in Wilson, North Carolina, USA
Curia Invests US$200 Million to Expand Facilities in the UK and USA
Curia is investing US$200 million to expand its sterile fillfinish facilities in Glasgow, UK, and Albuquerque, NM, USA
CordenPharma Constructs New Peptide Manufacturing Facility in Switzerland
CordenPharma is investing over US$540 million 500 million to construct a new peptide manufacturing facility in Muttenz, Switzerland The facility, located at Getec Park near Basel, is designed for small, medium, and largescale peptide production
NJEDA and Coriell Institute for Medical Research Invests US$41 million for State-of-the-Art Innovation Centre in UK
The New Jersey Economic Development Authority NJEDA and the Coriell Institute for Medical Research plan to invest US$41 million in the establishment of a stateoftheart Strategic Innovation Centre SIC in Camden
